Abstract:Ethnopharmacological relevance: Shenmai injection (SMI) is a CFDA-approved and widely prescribed herbal medicine injection in China for treating cardiac dysfunction, especially myocardial ischemia and reperfusion (I/R) injury. However, despite of its known clinical efficacy, the cardioprotective mechanisms of SMI remain to be established. Aim of study: The present study aimed to investigate the role of SMI on mitophagy and mitochondria] dynamics in cardiomyocytes with a hypoxia/reperfusion (H/R) injury setting. Materials and methods: H9c2 cardiomyocytes were subjected to 12 h of hypoxia followed by 2 h of reoxygenation to induce cellular injury. Multi-parameter imaging analysis was performed using Operetta High Content Imaging System to detect changes in mitochondrial function and morphological texture. The mPTP opening was directly assessed by analyzing mitochondrial calcein release in H9c2 and by Ca2+-induced swelling of isolated cardiac mitochondria. Mitochondrial respiration was measured by XF 24 analyzer of Seahorse Bioscience. RT-PCR and Western blotting analyses were used to detect mitophagy, mitochondrial fusion and fission biomarkers at the gene and protein levels. Results: Pretreatment of SMI significantly improved myocardial cell survival and protected against H/R-induced deterioration of mitochondrial structure and function, as evidenced by decreased mitochondrial mass and cytosolic Ca2+, increased mitochondrial membrane potential (Delta Psi(m)) and mitochondrial morphology by SER Texture analysis, inhibited mPTP opening in H9c2 cells and isolated cardiac mitochondria, and alleviated severely impaired mitochondrial respiration. Mechanistically, SMI attenuated H/R injury by inducing mitophagy and then modulated mitochondrial dynamics as indicated by a significantly increased expression of LC3, Beclin 1, Parkin and Pink, and the inhibition of excessive mitochondria fission and increased mitochondrial fusion. Finally, the cardioprotective effect of SMI was confirmed in a LAD-induced cardiac dysfunction model in vivo. Conclusion: We found that alleviation of H/R injury by pretreatment with SMI may be attributable to inducing mitophagy and modulating mitochondria! dynamics in cardiomyocytes, thereby providing a rationale for future clinical applications and potential mitoprotective therapy for MI/R injury.

Shengmai injection inhibits palmitic acid-induced myocardial cell inflammatory death via regulating NLRP3 inflammasome activation

Combined Treatment with Ultrasound-Targeted Microbubble Destruction Technique and NM-aFGF-loaded PEG-nanoliposomes Protects Against Diabetic Cardiomyopathy-Induced Oxidative Stress by Activating the AKT/GSK-3β1/Nrf-2 Pathway

Myocardial Protection by Salvia miltiorrhiza Injection in Streptozotocin-induced Diabetic Rats through Attenuation of Expression of Thrombospondin-1 and Transforming Growth Factor-beta 1

A Proteomic Study of Shengmai Injection's Mechanism on Preventing Cardiac Ischemia-Reperfusion Injury Via Energy Metabolism Modulation

Shengmai injection attenuates the cerebral ischemia/reperfusion induced autophagy via modulation of the AMPK, mTOR and JNK pathways

The Protective Effects of Shengmai Injectionon Experimental Myocardial Infarction in Rats

Shenmai Injection Alleviates Myocardial Ferroptosis via Activating the AKT1/mTOR Pathway in Rats with Acute Myocardial Infarction

Shengmai Injection Improved Doxorubicin-Induced Cardiomyopathy by Alleviating Myocardial Endoplasmic Reticulum Stress and Caspase-12 Dependent Apoptosis

Retraction Note: Emerging Protective Roles of Shengmai Injection in Septic Cardiomyopathy in Mice by Inducing Myocardial Mitochondrial Autophagy Via Caspase-3/Beclin-1 Axis

Shen-Fu Injection Preconditioning Inhibits Myocardial Ischemia-Reperfusion Injury in Diabetic Rats: Activation of Enos Via the PI3K/Akt Pathway

Mitochondrial Dynamics Modulation As a Critical Contribution for Shenmai Injection in Attenuating Hypoxia/reoxygenation Injury.

Effects of Shenfu Injectio on Expression of PTEN and PI3K During Myocardial Ischemia-Reperfusion in Diabetic Rats

EFFECT OF SHENGMAI INJECTION (SMI) ON BLOOD VASCULAR ENDODERMIS FUNCTION AND CARDIAC FUNCTION IN CORONARY ARTERY DISEASE WITH TYPE 2 DIABETES PATIENTS

study on the protective effect of the Mixture of Shengmai Powder and Danshen Decoction (生脉散丹参饮合剂) on the myocardium of diabetic cardiomyopathy in the rat model

Shenmai injection inhibits infIammatory response in IipopoIysaccharides-in-duced septic mice

Effect of Shengmai Injection on Cardiac Function and Inflammatory Reaction in Patients with Acute Coronary Syndrome

Effect of the Shumai Capsule on Apoptosis in Rats with Myocardial Ischemia

Effects of Shenmai injection against chronic heart failure: a meta-analysis and systematic review of preclinical and clinical studies

Shengmai San Alleviates Diabetic Cardiomyopathy Through Improvement of Mitochondrial Lipid Metabolic Disorder

Shenmai injection ameliorates doxorubicin-induced myocardial injury by suppressing autophagy-apoptosis via miR-30a

[Shenmai Injection Protects Mitochondria from Oxidative Injury in Myocardial Cells and Its Mechanism].